18.50

0.60% 0.11

Cellebrite Di Ltd (CLBT)

Overview News Price History Option Chain Discussions Forecast

Cellebrite Di Ltd stock is traded at $18.50, with a volume of 967.12K. It is up +0.60% in the last 24 hours and up +18.51% over the past month. Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Previous Close:

$18.39

Open:

$18.39

24h Volume:

967.12K

Relative Volume:

0.71

Market Cap:

$4.52B

Revenue:

$401.20M

Net Income/Loss:

$-283.01M

P/E Ratio:

-13.31

EPS:

-1.39

Net Cash Flow:

$121.56M

1W Performance:

+2.78%

1M Performance:

+18.51%

6M Performance:

+13.71%

1Y Performance:

-6.99%

1-Day Range:

$18.19

$18.63

1-Week Range:

$17.93

$18.64

52-Week Range:

$13.10

$26.30

Cellebrite Di Ltd Stock (CLBT) Company Profile

Name

Cellebrite Di Ltd

Sector

Technology (774)

Industry

Software - Infrastructure (161)

Phone

Address

Employee

1,167

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

CLBT's Discussions on Twitter

Compare CLBT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLBT Cellebrite Di Ltd	18.50	4.50B	401.20M	-283.01M	121.56M	-1.39
MSFT Microsoft Corporation	478.56	3.66T	293.81B	104.91B	78.02B	14.06
ORCL Oracle Corp	223.01	631.54B	59.02B	12.63B	-5.88B	4.3198
PLTR Palantir Technologies Inc	187.91	433.40B	3.90B	1.10B	1.79B	0.4275
CRWD Crowdstrike Holdings Inc	519.54	130.58B	4.57B	-315.36M	1.10B	-1.2634
SNPS Synopsys Inc	475.83	88.78B	6.43B	1.15B	1.30B	12.77

Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-28-24	Reiterated	Needham	Buy
Mar-13-24	Upgrade	William Blair	Mkt Perform → Outperform
Feb-16-24	Upgrade	BofA Securities	Neutral → Buy
Jul-19-23	Initiated	Craig Hallum	Buy
Aug-12-22	Downgrade	BofA Securities	Buy → Neutral
Aug-12-22	Downgrade	William Blair	Outperform → Mkt Perform
Feb-24-22	Initiated	JP Morgan	Overweight
Feb-11-22	Initiated	Deutsche Bank	Buy
Dec-02-21	Initiated	BofA Securities	Buy
Oct-21-21	Initiated	Citigroup	Buy

View All

Cellebrite Di Ltd Stock (CLBT) Latest News

Dec 10, 2025

Why Cellebrite Stock Is Skyrocketing Today - AOL.com

Dec 10, 2025

Norwood Investment Partners Opens New $4.3 Million Cellebrite Position - sharewise.com

Dec 10, 2025

Dec 09, 2025

Cellebrite Q3 2025 slides: 18% revenue growth amid digital investigation expansion By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 05, 2025

Cellebrite: Solid Setup Going Into Next Year (NASDAQ:CLBT) - Seeking Alpha

Dec 05, 2025

Cellebrite DI (CLBT) Is Up 8.1% After Q3 Beat And Corellium DealWhat's Changed - simplywall.st

Dec 05, 2025

Pertento Partners LLP Raises Stock Holdings in Cellebrite DI Ltd. $CLBT - MarketBeat

Dec 05, 2025

Quantbot Technologies LP Increases Position in Cellebrite DI Ltd. $CLBT - MarketBeat

Dec 05, 2025

Is Cellebrite DI Ltd. (9W9) stock safe for risk averse investorsJuly 2025 Technicals & Entry Point Strategy Guides - Newser

Dec 05, 2025

Dec 04, 2025

Officer Shapira Files To Sell 8,448 Of Cellebrite DI Ltd [CLBT] - TradingView

Dec 04, 2025

Entry Recap: Why Cellebrite DI Ltd stock is seen as undervalued2025 Buyback Activity & Fast Moving Stock Trade Plans - BỘ NỘI VỤ

Dec 04, 2025